Showing results (131-140 of 159) with videos related to
Sort By:
Pageof 16
Journal of the American Academy of Dermatology|November 10, 2019
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patientsAlan Menter, Kelly M Cordoro, Dawn M R Davis, et al.Journal of the American Academy of Dermatology|August 2, 2020
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measuresCraig A Elmets, Neil J Korman, Elizabeth Farley Prater, et al.Journal of the American Academy of Dermatology|July 29, 2019
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapyCraig A Elmets, Henry W Lim, Benjamin Stoff, et al.Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.Journal of the American Academy of Dermatology|October 8, 2011
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trialsKenneth B Gordon, Kim A Papp, Richard G Langley, et al.Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.Dermatology and Therapy|July 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 TrialsApril W Armstrong, Matthias Augustin, Jennifer L Beaumont, et al.Archives of Dermatology|December 17, 2003
A randomized trial of etanercept as monotherapy for psoriasisAlice B Gottlieb, Robert T Matheson, Nicholas Lowe, et al.Journal of the American Academy of Dermatology|March 3, 2020
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapiesAlan Menter, Joel M Gelfand, Cody Connor, et al.Dermatology and Therapy|January 20, 2022
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge StudyJeffrey J Crowley, Richard G Langley, Kenneth B Gordon, et al.Pageof 16